HCPCS Code J9041: Injection, Bortezomib (Velcade), 0.1 mg

Learn about the HCPCS code J9041 for "Injection, bortezomib (velcade), 0.1 mg" through this short guide.

## **What is the HCPCS code J9041 for?** The HCPCS code J9041 is a J code, meaning it's one of many HCPCS codes that designate the provision of medication. What is being designated for this code is the bortezomib injection, specifically every 0.1 mg of it. This is commonly referred to as a Velcade injection, and it can either be an intravenous or subcutaneous injection of a single-dose vial, depending on your recommendation as a healthcare professional. It's sometimes administered as a 3 to 5-second bolus intravenous injection. Its purpose is to combat certain cancers, such as multiple myeloma and certain lymphomas (e.g., diffuse large B cell lymphoma, mantle cell lymphoma, follicular lymphoma, lymph nodes, etc.). Other indications include antibody-mediated rejection of solid organ, pediatric classic Hodgkin lymphoma, and POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) syndrome, to mention a few. What this does is that it interferes with the protein degradation in cancer cells, leading to cell death. By doing this, it will slow down and stop the growth of cancer cells, and gradually reduce tumor sizes.

## **Documentation requirements for J9041** As with any HCPCS code, you need to have sufficient documentation that satisfies your insurer's coding guidelines, requirements, current procedural terminology, related policy articles (e.g., Medicare Part B), and local coverage determinations. Here are examples of what you need: - The full name of the patient - The full names and credentials of the professionals handling the patient - The name, address, and facility type of the place where the injection was administered - The relevant information and indications concerning the patient's condition/disease in their medical records to justify medical necessity - Drug information (e.g., name, strength, dose, total dose administered, manufacturer, lot number, National Drug Code, expiration date, etc.) - Signed provider order with information about the frequency and route - Any relevant tests (e.g., blood tests, imaging tests showing tumor locations and size) - Documentation of patient monitoring and responses (e.g., lab results, treatment progression, remission status)

## **Billing requirements J9041** Besides the documentation requirements above, please take note of or have the following: - 0.1 mg = 1 unit - Indicate the relevant ICD code applicable to your patient's condition - Indicate the relevant CPT codes applicable to the patient's treatment (e.g., CPT code 96401, 96409, etc.) - Use either of two modifiers: JW if there's unused medication in a vial (wastage), or JZ if there's no unused medication. - Prior authorization Again, please review what's needed concerning your insurer's service before filing any claims.

## **Other similar codes** - **J9046** - Injection, bortezomib (Dr. Reddy's), not therapeutically equivalent to J9041, 0.1 mg - **J9048** - Injection, bortezomib (Fresenius Kabi), not therapeutically equivalent to J9041, 0.1 mg - **J9049** - Injection, bortezomib (Hospira), not therapeutically equivalent to J9041, 0.1 mg - **J9051** - Injection, bortezomib (Maia), not therapeutically equivalent to j9041, 0.1 mg - **J9044** - Injection, bortezomib, not otherwise specified, 0.1 mg (lyophilized powder; this has been reported as terminated at present, so it can't be used)

Frequently asked questions

It'll take anywhere between 15 to 30 minutes. This is dependent on the dosage and route. It might take longer for IV route injections.

It's possible for the patient to feel nauseated and tired because of this injection. Rare complications include allergic reactions, low blood cell counts, and severe peripheral neuropathy.

Other chemotherapy drugs and radiation therapy are viable alternatives to this. Stem cell transplantation is also another course of treatment the patient can take.